Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| (NYSE: BHVN) | Delayed: 14.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.69 | 52 Week High | $ | |||
| Open | $14.69 | 52 Week Low | $ | |||
| Day High | $14.69 | P/E | N/A | |||
| Day Low | $14.69 | EPS | $ | |||
| Volume | 54,741 | |||||
